Interaction Evaluator
Peptide stack interaction checker
Select any combination of peptides and check it against documented contraindications, pharmacological-class conflicts, documented protocol matches, and likely synergies, with an at-a-glance 0–100 risk score.
What it checks
- Flagged conflicts, enumerated contraindications and class-level interactions (e.g. two GLP-1 receptor agonists, or a GHRH stacked with a GH secretagogue).
- Documented protocols, when the selection matches a documented protocol, the original protocol's rationale is surfaced.
- Likely synergies, complementary mechanisms reported in the literature.
- Effect-class coverage, which reported-effect categories the combination spans, and where it overlaps or is redundant.
How the risk score works
Each selection is scored 0–100 across documented contraindications, class conflicts, and overlap, then banded no findings → low → moderate → high → critical so a dangerous combination is obvious at a glance. Optional toggles layer in concurrent-medication context, insulin or a secretagogue, exogenous HGH, or anabolic-androgenic steroids.
What this tool does not do
- Does not provide medical advice or validate any dose, schedule, or combination for human use.
- Pattern-matches against currently documented interaction research, the absence of a flag is not affirmative safety, and pharmacology is incomplete and evolving.
Research reference only. Consult a qualified clinician before any human use.
Open the interactive PeptideHelper.org interaction evaluator to select peptides and read the conflicts, synergies, and risk score directly.
Frequently asked questions
How do I check if two peptides are safe to stack?
Select the peptides in the interaction evaluator. It flags documented contraindications and pharmacological-class conflicts (for example, stacking two GLP-1 receptor agonists, or a GHRH with a GH secretagogue), surfaces any documented protocol match, and returns a 0–100 risk score banded no findings to critical. Absence of a flag is not affirmative safety, it reflects currently documented research only.
What peptide combinations are flagged as dangerous?
The engine flags enumerated contraindications and class-based conflicts, duplicate-class agonists (two GLP-1s, two GHRHs), GH secretagogues combined with exogenous HGH, and combinations the literature reports as raising hypoglycemia or pituitary-feedback risk. A critical-tier score means at least one serious documented conflict was matched.
Does the evaluator account for insulin, HGH, or steroids taken alongside peptides?
Yes. Optional toggles can flag concurrent insulin, a sulfonylurea/secretagogue, exogenous HGH, or anabolic-androgenic steroids. When set, the engine layers in the relevant hypoglycemia, pituitary-feedback, and regulatory considerations for the selection.
Is a clean evaluation a guarantee that a stack is safe?
No. The evaluator pattern-matches against currently documented interaction research. A clean result means no documented conflict was matched in the catalog, not that the combination is affirmatively safe. Pharmacology is incomplete and evolving; consult a qualified clinician before any human use.
Loading interactive view…